SLU-PP-332 5mg

SLU-PP-332 5mg — ERRα Agonist Research Compound for Mitochondrial and Exercise Mimetic Studies

SLU-PP-332 is a small-molecule research compound that functions as a selective agonist of estrogen-related receptor alpha (ERRα), a master transcriptional regulator of mitochondrial biogenesis, oxidative phosphorylation, and energy metabolism. Often described in published literature as an “exercise mimetic” because it activates many of the same transcriptional programs triggered by endurance exercise, SLU-PP-332 has rapidly become an important research tool within the anti-aging peptides and metabolic research category.

ERRα Mechanism of Action

ERRα is a nuclear receptor that, despite its name, does not actually bind estrogen. Instead, ERRα regulates expression of hundreds of genes involved in mitochondrial function, fatty acid oxidation, and oxidative metabolism. SLU-PP-332 binds the ERRα ligand-binding domain and stabilizes the receptor in its transcriptionally active conformation, mimicking many of the gene expression changes normally induced by exercise training in animal models.

Mitochondrial Biogenesis Research

Studies have documented that SLU-PP-332 treatment increases mitochondrial density, enhances mitochondrial protein expression, and improves oxidative capacity in skeletal muscle. These mitochondrial adaptations represent one of the most fundamental cellular changes induced by endurance training, and SLU-PP-332 provides researchers with a pharmacological tool to dissect this process from the confounding variables of physical exercise.

Exercise Capacity and Endurance Research

Preclinical research has demonstrated that SLU-PP-332 administration improves exercise capacity and endurance performance in animal models. Studies have shown extended time to exhaustion, increased running distance, and improved metabolic flexibility in treated animals, with effects comparable to those induced by chronic exercise training in matched controls.

Metabolic Disease Research

Given its effects on metabolic gene expression, SLU-PP-332 has attracted interest in metabolic disease research. Studies have examined effects on obesity, insulin resistance, and metabolic syndrome biomarkers in animal models, with documented improvements in body composition, glucose tolerance, and lipid profiles in treated animals.

Aging and Longevity Research

Mitochondrial dysfunction is recognized as a hallmark of aging, and SLU-PP-332’s mitochondria-supporting effects have positioned it as a tool for investigating aging mechanisms. Research has examined effects on age-related decline in muscle function, oxidative capacity, and metabolic flexibility, supporting use of SLU-PP-332 in longevity-focused experimental designs.

Comparison With Related Anti-Aging Research Compounds

SLU-PP-332 is frequently studied alongside other mitochondrial and longevity research compounds such as MOTS-c, Humanin, and Epithalon. Parallel investigations help characterize how nuclear receptor agonism via ERRα compares with mitochondrial-derived peptide signaling in matched experimental designs.

Quality, Storage, and Compliance

Each vial of SLU-PP-332 5mg is manufactured to 99%+ HPLC-verified purity and supplied as a sterile lyophilized powder. Store unreconstituted vials at -20°C; reconstituted material should be refrigerated at 2–8°C. This SLU-PP-332 product is sold strictly for in-vitro laboratory research only — not for human consumption, diagnostic use, or any clinical application. Buyers must comply with all applicable provincial and federal regulations.